STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,325 | -66.1% | 79,524 | -8.5% | 0.00% | -66.7% |
| Q2 2023 | $923,439 | +62.6% | 86,871 | +27.4% | 0.00% | +50.0% |
| Q1 2023 | $568,064 | +38.8% | 68,195 | +53.8% | 0.00% | +100.0% |
| Q4 2022 | $409,304 | +108.8% | 44,345 | +191.2% | 0.00% | 0.0% |
| Q3 2022 | $196,000 | +4.3% | 15,230 | +6.8% | 0.00% | – |
| Q2 2022 | $188,000 | -77.7% | 14,259 | -64.4% | 0.00% | -100.0% |
| Q1 2022 | $842,000 | +102.9% | 40,000 | +131.2% | 0.00% | +100.0% |
| Q4 2021 | $415,000 | -5.7% | 17,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $440,000 | -24.4% | 17,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $582,000 | -13.4% | 17,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $672,000 | -37.3% | 17,300 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,071,000 | +64.0% | 17,300 | -11.3% | 0.00% | 0.0% |
| Q3 2020 | $653,000 | +40.4% | 19,500 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $465,000 | +44.0% | 19,500 | +38.3% | 0.00% | 0.0% |
| Q1 2020 | $323,000 | -18.0% | 14,100 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $394,000 | +31.8% | 13,900 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $299,000 | – | 13,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $1,062,825,000 | 82.06% |
| RTW INVESTMENTS, LP | 3,544,248 | $219,495,000 | 3.68% |
| Cormorant Asset Management, LP | 1,437,807 | $89,043,000 | 2.12% |
| Redmile Group, LLC | 2,686,234 | $166,358,000 | 2.01% |
| ACUTA CAPITAL PARTNERS, LLC | 92,500 | $5,729,000 | 1.56% |
| Pinz Capital Management, LP | 34,200 | $2,118,000 | 0.96% |
| Birchview Capital, LP | 20,000 | $1,239,000 | 0.71% |
| HighVista Strategies LLC | 17,668 | $1,094,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 1,470,841 | $91,089,000 | 0.45% |
| Perceptive Advisors | 671,978 | $41,616,000 | 0.45% |